This Week in Biopharma Deals, by biodealroom

TWiBD: Pfizer's $6.95B Metsera Buy — Because Obesity Portfolios Are the New Black?

TWiBD: Roche to buy 89bio for up to $3.5B — Pegozafermin’s FGF21 bet goes big

September 15-19, 2025

Big Pharma Wraps 2024 with a Deal-Making Bow

Week 50 Deals (2024)

18 deals this week: BD Teams are making their 2024 goals!

Week 49 (2024)

The CAR-Ts and the Bees

Week 48 Deals (2024)

Slicing off a piece of aficamten for Bayer

Week 47 Deals (2024)

Merck strikes back against the Duggan empire (Summit Therapeutics)

Week 46 Deals (2024)

A non-traditional week ahead of the season of traditions

Week 45 (2024)

The leaves are falling, but these deals keep piling up—who says biotech hibernates for winter?

Week 44 Deals (2024)

Neurology, Oncology, and Rare Diseases: A Week of Deals Across the Spectrum

Week 43 Deals (2024)

Novo isn't the only company in Denmark 😉

Week 42 Deals (2024)

Strategic acquisitions and collaborations dominate the week

Week 41 Deals (2024)